Home
Our Story
Meet The Team
Pipeline
Press Releases
Contact
Publications
More
Sparian Biosciences
Sparian Biosciences is a clinical stage bio-pharmaceutical company focusing on discovering and developing new therapies to target the central nervous system (CNS).
Press Release
NEW YORK, NY, February 23, 2023 -- Sparian Biosciences Announces Initiation of Phase 1 Clinical Trial of First-In-Class Arylepoxamide Agonist, SBS-1000, for the Treatment of Pain ...